1. Home
  2. ACR vs ANTX Comparison

ACR vs ANTX Comparison

Compare ACR & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACR

ACRES Commercial Realty Corp.

HOLD

Current Price

$12.55

Market Cap

146.1M

Sector

Real Estate

ML Signal

HOLD

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$4.86

Market Cap

172.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACR
ANTX
Founded
2005
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
146.1M
172.9M
IPO Year
2005
2022

Fundamental Metrics

Financial Performance
Metric
ACR
ANTX
Price
$12.55
$4.86
Analyst Decision
Buy
Buy
Analyst Count
1
1
Target Price
$24.50
$2.00
AVG Volume (30 Days)
31.6K
189.9K
Earning Date
04-30-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.56
EPS
N/A
N/A
Revenue
$79,946,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.57
$1.00
52 Week High
$24.61
$7.19

Technical Indicators

Market Signals
Indicator
ACR
ANTX
Relative Strength Index (RSI) 31.56 33.25
Support Level N/A $4.55
Resistance Level $14.97 $5.21
Average True Range (ATR) 0.53 0.36
MACD -0.02 -0.11
Stochastic Oscillator 17.59 5.33

Price Performance

Historical Comparison
ACR
ANTX

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding, and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralized debt obligations, and private equity investments mainly issued by financial institutions.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Share on Social Networks: